Has anyone here heard anything of the trial by Intercept Pharmaceutical? Were you impressed with the results? This is the first paragraph from the article in the Boston Globe:
Intercept Pharmaceuticals said Thursday that an extensive re-analysis of a large clinical trial involving its experimental treatment for the fatty liver disease known as NASH once again achieved its primary efficacy goal.